Loading...
Publication
Recomendações para a Implementação da medicina genómica nos sistemas de saúde: principais conclusões das Country Exchange Visits ao Reino Unido, Estónia e Finlândia
| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 1.41 MB | Adobe PDF |
Advisor(s)
Abstract(s)
Para que todos os cidadãos europeus possam vir a beneficiar da medi cina genómica de forma equitativa, é essencial colmatar as assime trias existentes na Europa na implementação das análises genómicas
nos cuidados de saúde. Promover o diálogo e a cooperação entre
países, contribuindo para a sua capacitação e partilha de boas práticas, é essencial para o avanço da medicina genómica a nível nacional e europeu. Nesse sentido, o projeto Beyond 1 Million Genomes
(B1MG) organizou três Country Exchange Visits (CEVs) a países europeus com estratégias genómicas avançadas, nomeadamente o Reino
Unido, a Estónia e a Finlândia. Estas visitas promoveram uma discus são aberta sobre os pontos-chave para a implementação sustentável
da medicina genómica nos serviços de saúde. Profissionais de saúde
e investigadores dos países signatários da iniciativa europeia de 1
Milhão de Genomas (1+MG) participaram nesses eventos, alguns dos
quais apresentaram as respetivas iniciativas nacionais para a medi cina genómica. Com base nas boas práticas apresentadas, e em exemplos reais dos países anfitriões, foram propostas recomendações em
áreas essenciais à implementação sustentável da medicina genómica
nos sistemas de saúde europeus, nomeadamente: (i) o envolvimento
dos cidadãos e dos doentes; (ii) o investimento em infraestruturas e
a regulamentação na prática clínica; (iii) a formação e capacitação de
profissionais de saúde; (iv) a construção de um ecossistema sustentável baseado em sinergias entre sistemas de saúde, investigação e
indústria.
For genomic medicine to become accessible to all European citi zens, it is essential to bridge the current gaps across European countries regarding the maturity of genomics use in health care. Promoting dialogue and cooperation between countries, contributing to capacity building and sharing best practices is thus essential for the advancement of genomic medicine at national and European levels. The Beyond 1 Million Genomes (B1MG) project is a Coordination and Support Action funded by the European Commission, to assist the 1+ Million Genomes Initiative. The 1+MG Initiative engages 26 European countries in the development of a framework for genomic and health data access across borders, to facilitate research and perso nalised medicine in Europe. To improve cooperation across European health systems, the B1MG project organized three Country Exchange Visits (CEVs) to countries with well advanced genomic strategies, namely the United Kingdom, Estonia and Finland, to discuss the critical factors for the sustainable implementation of national strategies for genomic medicine. Researchers and health professionals involved in the 1+MG Initiative participated in these events, and 13 countries presented the status of their genomic medicine strategies. Based on the presentations and discussions, a set of recommendations for the successful implementation of genomic medicine in European health systems were proposed in four key areas: patient and citizen engagement; infrastructure and regulation for implementation of genomics into clinical practice; workforce education and training; and building a sustainable ecosystem based on synergies between clinical practice, research and industry
For genomic medicine to become accessible to all European citi zens, it is essential to bridge the current gaps across European countries regarding the maturity of genomics use in health care. Promoting dialogue and cooperation between countries, contributing to capacity building and sharing best practices is thus essential for the advancement of genomic medicine at national and European levels. The Beyond 1 Million Genomes (B1MG) project is a Coordination and Support Action funded by the European Commission, to assist the 1+ Million Genomes Initiative. The 1+MG Initiative engages 26 European countries in the development of a framework for genomic and health data access across borders, to facilitate research and perso nalised medicine in Europe. To improve cooperation across European health systems, the B1MG project organized three Country Exchange Visits (CEVs) to countries with well advanced genomic strategies, namely the United Kingdom, Estonia and Finland, to discuss the critical factors for the sustainable implementation of national strategies for genomic medicine. Researchers and health professionals involved in the 1+MG Initiative participated in these events, and 13 countries presented the status of their genomic medicine strategies. Based on the presentations and discussions, a set of recommendations for the successful implementation of genomic medicine in European health systems were proposed in four key areas: patient and citizen engagement; infrastructure and regulation for implementation of genomics into clinical practice; workforce education and training; and building a sustainable ecosystem based on synergies between clinical practice, research and industry
Description
Keywords
Medicina Genómica Implementação Sistemas de Saúde Country Exchange Visits Reino Unido Estónia Finlândia Recomendações Medicina Personalizada Doenças Genética
Pedagogical Context
Citation
Boletim Epidemiológico Observações. 2023 janeiro-abril;12(33):6-12
Publisher
Instituto Nacional de Saúde Doutor Ricardo Jorge, IP